IMMUNOGL. SNAKE ANTIVENOM, Middle East countr., 10ml, amp.
NST
DVACIMAS1AME
Valid Article
HS Code:
{}
Last Updated on:
12/04/2024, 17:48:40
Former
Code(s):
DVACZNL0050 DVACIMAS1A
19.2 - Sera, immunoglobulins and monoclonal antibodies
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J06AA03
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
IMMUNOGLOBULIN SNAKE ANTIVENOM, Middle East NAVPC
This product is not always available at the central supply level. Contact your HQ advisor and check the specifications if an alternative is offered.
Therapeutic Action
Neutralisation of snake venom
Equine serum globulins
Indications
IMMUNOGLOBULIN SNAKE ANTIVENOM, Middle East, NAVPC
Treatment of envenomations from snakes bites found in Middle East and North Africa:
- Puff adder (Bitis arietans)
- Horned desert viper (Cerastes cerastes)
- Saw-scaled viper (Echis carinatus)
- Mid-east saw scaled viper (Echis coloratus)
- Egyptian cobra (Naja haje)
- Desert black snake (Walterinnesia aegyptia)
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
- Read the manufacturer's instructions.
Precautions for Use
Appropriate medical treatment should always be readily available in case of anaphylactic reactions following the administration of the product.
Storage
- Keep refrigerated between 2ºC and 8ºC - Protect from sunlight
- Do not freeze.